U.S. Healthcare Services Stock News

If you are wondering whether Datadog's current share price reflects its true worth, you are not alone. This article will focus on what the numbers say about value rather than just the story. Datadog shares last closed at US$118.33, with returns of 7.3% over 7 days, an 8.3% decline over 30 days, an 11.5% decline year to date, a 2.8% gain over 1 year, 64.4% over 3 years and 46.6% over 5 years. This gives a mixed picture for investors thinking about entry or exit points. Recent headlines around...

Snap stock reaction and recent performance context Snap (SNAP) has drawn fresh attention as investors reassess the visual messaging company after its recent trading performance, with the stock showing mixed short term moves and weaker returns over the past year. See our latest analysis for Snap. At a share price of US$5.37, Snap has seen some short term support with a 1 day share price return of 2.29% and 7 day share price return of 5.92%. However, the 30 day and year to date share price...

Sigma Lithium recently presented at the 35th BMO Global Metals, Mining & Critical Minerals Conference in Florida and has scheduled its fourth quarter 2025 earnings release and conference call for March 30, 2026, while continuing construction of a second plant at its Grota do Cirilo operation in Brazil. In parallel, BofA Securities upgraded the company after it restarted mining and secured a large high-purity lithium fines sales agreement, which together ease liquidity pressures and underline...

Mississippi Power, a subsidiary of Southern (NYSE:SO), has appointed Fredie Carmichael as vice president of Customer Solutions and Corporate Communications. The new leadership role centers on customer engagement, corporate messaging, and related initiatives across Mississippi Power's service areas. For investors watching Southern at a share price of $97.63, this move adds a fresh voice to one of its key operating companies. Mississippi Power's focus on customer solutions and communications...

nLIGHT (LASR) is back on investors’ radar after unveiling a 70kW-class laser weapon system and leaning further into defense work, with attention building ahead of a planned showcase at the POST Conference. See our latest analysis for nLIGHT. The latest defense focused announcements are landing against very strong momentum, with a 30 day share price return of 39.39%, a 90 day share price return of 84.42%, and a 1 year total shareholder return that is many times the starting level. If this...

Why Pebblebrook Hotel Trust stock is in focus now Pebblebrook Hotel Trust (PEB) is back on investors radar after its fourth quarter and full year 2025 earnings, fresh 2026 guidance, and an update on a sizeable share repurchase program. The company reported fourth quarter 2025 sales of US$210.94 million, with revenue of US$349.02 million and a net loss of US$17.85 million. For the full year, revenue reached US$1.48b and the net loss was US$65.81 million. Management also outlined expectations...

Protagonist Therapeutics stock: recent move puts biotech name on investor radar Protagonist Therapeutics (PTGX) has drawn fresh interest after recent share price strength, with the stock last closing at US$94.83 and showing double digit gains over the past month and past 3 months. See our latest analysis for Protagonist Therapeutics. The recent 14.2% 1 month share price return and 8.8% year to date share price return sit alongside a very strong 1 year total shareholder return of 146.6%,...

In February 2026, Boyd Gaming announced the upcoming retirement of Chief Administrative Officer Stephen Thompson and raised its quarterly dividend from US$0.18 to US$0.20 per share, payable on April 15, 2026, to shareholders of record on March 16, 2026. This combination of leadership change and a dividend increase highlights management’s focus on capital returns while maintaining continuity in the company’s broader operating and financial approach. Next, we’ll examine how Boyd Gaming’s...

Cboe Global Markets reported record-breaking trading volumes across its global business lines in February. The company set monthly average daily volume records in its proprietary index options. Cboe also reported new highs in trading activity across its European trading operations. Cboe Global Markets, ticker BATS:CBOE, is drawing fresh attention after reporting record trading volumes in February, with new highs in its index options and European operations. The stock last closed at $300.62,...

Kyndryl Holdings (NYSE:KD) has been hit with multiple securities class action lawsuits following disclosures of material weaknesses in its internal controls. The company also reported the departures of key executives, including its Chief Financial Officer and General Counsel. Investors are assessing what these control issues and leadership changes could mean for financial reporting quality and potential legal exposure. Kyndryl Holdings, trading at about $13.14, has seen sharp volatility,...

If you have ever wondered whether Netflix's share price really reflects what you are paying for, this breakdown will help you separate story from numbers. Netflix closed at US$98.66, with returns of 16.6% over the past week, 23.4% over the past month, 8.4% year to date, 8.9% over one year, and a very large return over three years that is described as 231.3% and 88.6% over five years. Recent headlines around Netflix have continued to focus on its position in global streaming and its efforts...

Recent trading performance Aktis Oncology (AKTS) has drawn fresh attention after recent share price moves, with the stock up 3.1% over the past day and 6.9% over the past week, despite a 5.1% decline over the past month. For context, the Boston based clinical stage company focuses on targeted radiopharmaceutical therapies. It reported US$5.56 in revenue and a net loss of US$60.649, while shares most recently closed at US$20.85. See our latest analysis for Aktis Oncology. That recent 1-day and...

If you are wondering whether Johnson & Johnson is trading at a fair price today, you are not alone. The mix of a strong brand and changing headlines has many investors asking what the stock is really worth. Over the past week the share price return was 0.1%. Over the last month it was 6.3%. Year to date it was 18.3%. Over 1 year and 5 years the returns were 52.7% and 77.5% respectively, which can affect how much upside or downside investors feel is left in the story. Recent news around...

Wondering whether Tyler Technologies at US$368.16 is starting to look interesting on value, or if the price still feels a bit rich for what you are getting. The stock has moved 9.9% over the last 7 days and 1.5% over 30 days, while the year to date return sits at a 15.5% decline and the 1 year return at a 41.1% decline, with a 12.7% 3 year return and an 8.1% decline over 5 years. These mixed returns mean recent news and sentiment matter for how investors are looking at Tyler Technologies...

In early March 2026, Alignment Healthcare filed an omnibus shelf registration and a selling stockholder completed a US$256.24 million secondary offering of 13,167,733 common shares at US$19.46 each under that shelf. These transactions, alongside the company’s strong 2025 results and upbeat 2026 revenue and EBITDA guidance, highlight rising investor interest despite no new capital going to Alignment itself. We’ll now examine how this secondary offering by a major shareholder, paired with...

Buckle (BKE) just released its latest 4 week sales update, reporting comparable store net sales up 8.0% and total net sales rising 8.8% to US$84.4 million for the period. See our latest analysis for Buckle. At a share price of US$53.0, Buckle has recently seen a 10.1% 1 month share price return. Its 1 year total shareholder return of 52.9% and 5 year total shareholder return of 124.0% point to strong longer term gains, suggesting recent sales updates may be reinforcing momentum after some...

Earnings and collaboration put Tango Therapeutics (TNGX) in focus Tango Therapeutics (TNGX) is drawing fresh attention after reporting its fourth quarter and full year 2025 results, alongside a new clinical trial collaboration with Erasca that combines two targeted agents for MTAP-deleted cancers. See our latest analysis for Tango Therapeutics. The earnings update and new Erasca collaboration come after a strong run, with Tango’s 90 day share price return of 24.75% and a very large 1 year...

Viavi Solutions (VIAV) is back on investors' radar after a sharp stock move tied to fresh analyst confidence, management commentary on end markets, and new wins in AI driven networking and optical testing. See our latest analysis for Viavi Solutions. Those AI and 6G projects have landed at a time when momentum in the stock has clearly picked up. A 30 day share price return of 27.35% has fed into a 90 day share price return of 86.23% and a 1 year total shareholder return of 188.66%. This...

Genius Sports (GENI) has just posted another loss making quarter, with Q3 FY 2025 revenue of US$166.3 million and a basic EPS loss of US$0.11 as the company continues to push for scale in sports data and betting technology. Over recent periods, revenue has moved from US$95.4 million in Q2 2024 to US$120.2 million in Q3 2024 and US$166.3 million in Q3 2025, while quarterly EPS has swung between a profit of US$0.05 in Q3 2024 and losses of US$0.12 in Q4 2024, US$0.03 in Q1 2025, US$0.21 in Q2...

First Bancorp (FBNC) is drawing attention after president and CEO Michael G. Mayer retired effective February 28, 2026, while remaining on the board, alongside new board responsibilities for Adam Currie and an analyst rating upgrade. See our latest analysis for First Bancorp. At a share price of US$58.12, First Bancorp’s recent 7 day and 30 day share price returns have been slightly negative, while its 90 day gain of 12.61% and 1 year total shareholder return of 46.85% suggest momentum has...

In recent days, multiple major banks and research firms have initiated upbeat coverage on newly public Forgent Power Solutions, which raised about US$1.50 billion in its IPO and focuses on electrical distribution equipment for data centers, utilities, and industrial customers. What makes this coverage stand out is the rare alignment of Wall Street analysts and high-profile media voices highlighting Forgent’s ability to supply engineered, end-to-end powertrain solutions to an...

XPO (XPO) has returned to positive year over year tonnage growth in its North American LTL segment for the first time since June 2024, paired with management’s focus on cost and efficiency. See our latest analysis for XPO. That operational shift has arrived alongside powerful share price momentum, with a 31.52% 1 month share price return, 52.26% 3 month share price return and a 90.24% 1 year total shareholder return. This suggests investors are reassessing both growth potential and risk. If...

Ducommun (NYSE:DCO) executives are scheduled to present at the Sidoti Small Cap Conference. The appearance includes a general company presentation and one on one investor meetings. A live webcast and replay of the presentation will be available for investors and other stakeholders. Ducommun, an established supplier to the aerospace and defense sectors, is using the Sidoti Small Cap Conference to speak directly to the broader investment community. For you as an investor, the mix of a public...

Eversource Energy recently completed and announced a US$750,000,000 fixed-to-floating rate junior subordinated unsecured notes offering, with variable coupons and a 2056 maturity. This long-dated, callable debt issue highlights the company’s focus on securing flexible, long-term financing to support its regulated utility operations. Next, we’ll examine how this US$750,000,000 junior subordinated, variable-rate issuance may influence Eversource’s investment narrative and risk profile. We've...